Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258544 · ClinicalTrials.gov registry record
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
A clinical trial of Pulmonary Fibrosis, sponsored by University of Pittsburgh.
- Active
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT00258544 is a study of Pulmonary Fibrosis that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 80 participants, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00258544, a study of Pulmonary Fibrosis, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead to new approaches to the diagnosis and treatment of pulmonary fibrosis.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2001-10 |
| Est. Completion | 2030-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00258544
The ClinicalTrials.gov registry entry for NCT00258544 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (91% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00258544 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00258544 about?
NCT00258544 is a clinical study titled "Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)". This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead t...
What is the current status of trial NCT00258544?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2001-10. Estimated completion is 2030-07.
What conditions does trial NCT00258544 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis.
Who is sponsoring clinical trial NCT00258544?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00258544 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.